Fig. 9
From: SLC26A4 correlates with homologous recombination deficiency and patient prognosis in prostate cancer
Validation of SLC26A4 in Xiangya cohort. A Expression difference of SLC26A4 mRNA and IHC between PCa and BPH tissues. B ROC curves of age, baseline PSA, and SLC26A4 mRNA and IHC in distinguishing PCa and BPH samples. C Expression difference of SLC26A4 mRNA and IHC between HRD and non-HRD PCa tissues. D ROC curves of age, Gleason score, baseline PSA, and SLC26A4 mRNA and IHC in distinguishing HRD and non-HRD PCa samples. Representative immunohistochemical results of E BPH, F HRD PCa, and G non-HRD PCa samples